Skip to content

Flapless Mini-incision Implant Surgery

Flapless Mini-incision Implant Surgery vs Conventional Flap or Flapless Implant Surgery: A Prospective, Randomized, Single Blind, Clinical and Radiographic Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07008079
Enrollment
90
Registered
2025-06-06
Start date
2025-06-16
Completion date
2025-07-31
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Dental Implant Placement, IMPLANTATION, Peri-Implant Tissues

Keywords

flapless surgery, mini-incision surgery, peri-implant soft tissue, dental implant

Brief summary

evaluate the clinical efficacy of the flapless mini-incision method compared to conventional flap and flapless punch methods

Interventions

PROCEDUREFlapless punch

use of flapless puch surgery to place dental implants

PROCEDUREFlapless mini-incision

Use of a flapless mini-incision to place a dental implant

Use of a conventional surgical flap to place a dental implant

Sponsors

Alaa Emara
Lead SponsorOTHER
King Saud University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients with adequate bone height and width at the site of implant 120 placement, and good quality bone to support a primary stability of at least 30 Ncm and D2 bone quality according to Lekholm and Zarb classification), based on preoperative radiographic assessment * Clinical evidence of optimal periodontal health with no active periodontal disease in adjacent teeth * No history of systemic illnesses that could affect bone health and wound heal- ing (e.g. uncontrolled diabetes mellitus, osteoporosis, renal osteodystrophy…etc.) * No history of or requirement for bone grafting and augmentation at the implant site * Willingness to participate in the study and attend prescribed follow-up appointments

Exclusion criteria

* Patients with history of radiation therapy for head and neck cancer * Patients with history of allergy and hypersensitivity to local anesthetic agents, and biomaterials used in dental implants * Pregnant women and lactating mothers * History of smoking (\>2 cigarettes per day) * Patients under treatment with anti-resorptive or anti-neoplastic medication such as bisphosphonates, chemotherapeutic agents, and monoclonal antibodies (e.g. Denosumab

Design outcomes

Primary

MeasureTime frameDescription
Pain score18 months postoperativelyAssessment of patient's pain level using Visual Analog Scale (VAS) which would be compared between groups. VAS is a visual scale 0 to 10 with 10 the highest pain score and 0 the lowest, the patient is asked to identify the pain level at the different timestops for comparison between groups

Secondary

MeasureTime frameDescription
Soft-tissue healing18 months postoperativelyAssess the healing of overlaying soft tissue. Check for signs of infection , swelling, dehiscnce or inflammation
Radiographic bone level18 months postoperativelyAssessment of bone level postoperatively. A CBCT is ordered to assess bone density in hounsfeld unitsto assess level of bone maturation. This would then be compared across groups and between different time points to show bone deposition and healing.

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026